Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-21 Purchase |
2021-06-22 5:09 pm |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
1,000 | $6.81 | $6,810 | 36,510 (Direct) |
View |
| 2020-10-01 Purchase(A) |
2020-10-05 5:33 pm |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,000 | $4 | $24,000 | 47,248 (Direct) |
View |
| 2020-10-01 Purchase |
2020-10-05 4:43 pm |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,000 | $2.1 | $12,600 | 47,248 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-05 Exercise |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
2,319 | $0 | 120,438 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
282 | $1.71 | 120,438 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,154 | $0 | 120,438 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
518 | $2.79 | 120,438 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 4:57 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
1,675 | $0 | 30,157 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 4:57 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
518 | $2.79 | 30,157 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:58 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
15,000 | $0.33 | 99,250 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
22,500 | $0.24 | 84,250 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:20 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
12,500 | $0.8 | 61,750 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:42 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
178,768 | $0 | 1,293,326 (Direct) |
View |
| 2022-09-30 Option Award(A) |
2022-10-05 4:40 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
12,950 | $0 | 339,663 (Direct) |
View |
| 2022-06-30 Option Award |
2022-10-03 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
23,947 | $0 | 326,713 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
7,601 | $0 | 49,250 (Direct) |
View |
| 2022-08-05 Tax Withholding |
2022-08-09 4:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
2,462 | $3.17 | 49,250 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:35 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
23,947 | $0 | 326,713 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-11 5:54 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
247,841 | $0 | 302,766 (Direct) |
View |
| 2021-11-01 Option Award |
2022-04-04 5:46 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
15,001 | $0 | 64,847 (Direct) |
View |
| 2021-12-31 Option Award(A) |
2022-01-06 5:21 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,722 | $0 | 22,780 (Direct) |
View |
| 2021-09-30 Option Award(A) |
2022-01-06 4:07 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,024 | $0 | 16,058 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 5:27 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,722 | $0 | 6,722 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:38 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,024 | $0 | 6,024 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 4:38 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
7,601 | $0 | 44,111 (Direct) |
View |
| 2021-07-08 Option Award |
2021-07-09 4:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
23,337 | $0 | 31,464 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:06 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
8,127 | $0 | 8,127 (Direct) |
View |
Ownership |
2020-10-02 4:46 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
0 | $0 | 105,543 (Direct) |
View |